TECXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Tectonic Therapeutic, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$21.15+0.50 (+2.42%)
Close on Oct 19, 2026
- Market cap
- $401.09M
- P/E (TTM)
- –
- Dividend yield
- 0.00%
Share price
+$3.89 (+22.54%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $401.09M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.79
- Dividend yield
- 0.00%
- Free cash flow yield
- -18.06%
Fundamentals
- Net income
- -$85.79M
- EPS, diluted
- -$4.57
- Free cash flow
- -$72.42M
- Book value per share
- $11.80
- Diluted shares
- 19M
Ten years at a glance
Fiscal years 2016 to 2025 and trailing twelve months, USD
Operating income
-$94.93M
Net income
-$85.79M
EPS, diluted
-$4.57
Free cash flow
-$72.42M
Reported periodTrailing twelve months